Big effect
Bifidobacterium slashed a marker of oxidative stress by a large margin in a meta-analysis — but the effect was strongest in people under 70 with existing cognitive decline.
This is among the first meta-analyses to link Bifidobacterium to a sharp drop in malondialdehyde (a marker of cell damage), but the finding comes from a clinical population with cognitive impairment, so it's too early to assume the same benefit for healthy adults.
Malondialdehyde (MDA) is a byproduct of oxidative stress that can damage cells. In a meta-analysis of 18 studies involving 1,195 people with cognitive impairment or dementia, Bifidobacterium supplementation reduced MDA levels by a large amount (standardized mean difference of -0.72). However, the effect was most pronounced in participants under 70, and the overall body of evidence on this specific pairing is still very new.
Where this fits in the evidence
This is among the first studies we've indexed on Bifidobacterium for Reduced Malondialdehyde — treat it as an early signal until more research accumulates.
The study
- Meta-Analysis
- n = 1,195
- 2025-09
- Ageing research reviews
This is a plain-language summary of a research finding, not medical advice. Pillser surfaces research signals to help you decide what's worth investigating — always consult a qualified professional before changing what you take.